Related Experiment Video

Updated: Jun 11, 2025

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

19.7K

[Management of pediatric immune thrombocytopenia]

Makiko Mori1

  • 1Department of Hematology/Oncology, Saitama Children's Medical Center.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|October 2, 2024
PubMed

Insights

New pediatric immune thrombocytopenia (ITP) guidelines emphasize quality of life, incorporating a modified bleeding score. Treatment strategies now focus on multidimensional patient well-being, including novel therapies targeting Syk, BTK, and FcRn pathways.

Area of Science:

  • Hematology
  • Pediatrics
  • Immunology

Context:

  • Updated guidelines for pediatric immune thrombocytopenia (ITP) have been released.
  • The disease name and staging criteria have been revised.
  • A modified Buchanan's bleeding score is introduced for symptom assessment.

Purpose:

  • To outline current best practices for managing pediatric ITP.
  • To emphasize a multidimensional approach to treatment goals.
  • To highlight emerging therapeutic targets and future directions.

Summary:

  • Revised guidelines for pediatric immune thrombocytopenia (ITP) incorporate a modified Buchanan's bleeding score.
  • Treatment aims to enhance health-related quality of life (HRQoL) by considering platelet counts, bleeding, activity, lifestyle, and healthcare access.
  • First-line therapies include IVIG and corticosteroids; second-line options include TPO-RAs, rituximab, and splenectomy.

Impact:

  • Provides clinicians with updated management strategies for pediatric ITP.
  • Shifts focus towards patient-centered outcomes and quality of life.
  • Identifies promising novel therapeutic targets like Syk, BTK, and FcRn for future drug development.

Keywords:
Health-related quality of life (HRQoL)Immune thrombocytopeniaRituximabThrombopoietin-receptor agonist (TPO-RA)

More Related Videos

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System12:40

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

28.7K
Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization08:13

Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization

Published on: December 3, 2020

4.6K

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
3
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
3
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
313
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
3
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
916